GLP Agonists is an editorial publication covering the GLP-1 telehealth market — pricing, pharmacy sourcing, clinical oversight, and patient experience — held to a published rubric and reviewed by licensed clinicians.
Health journalists, a clinical pharmacist, and a U.S.-licensed physician reviewer.
Amanda is the lead editor at GLP Agonists, responsible for editorial direction, the scoring methodology, and provider review accuracy. Her work covers telehealth, digital health access, and consumer pricing transparency.
Dr. Kennah is a U.S.-licensed physician who reviews medication and dosing content for clinical accuracy and oversees editorial coverage on prescription topics. He reviews every provider profile and the scoring methodology before publication.
Dr. Berg is a licensed clinical pharmacist with twelve years of experience focused on cardiometabolic and endocrine medications, including GLP-1 receptor agonists. He reviews pharmacy-sourcing claims and USP-related coverage for technical accuracy.
Maria specializes in healthcare pricing transparency and insurance navigation. She researches and fact-checks all provider pricing, verifies claims against published company sources, and maintains the pricing-comparison data set on a quarterly cadence.
GLP Agonists earns commission when readers sign up to certain providers through links on this site. We disclose this prominently on every page. Partnership status is not an input to the scoring rubric. A provider does not earn a higher position by becoming a partner, and partners are not protected from category losses. Where a partner ranks ahead of a competitor, that ranking reflects the rubric output — not the commercial relationship.
Every claim of fact about a provider — pricing, pharmacy sourcing, USP testing, state availability, certification status — is sourced to a primary, citable document, typically the provider's own published material or a recognized regulatory body. Citations are numbered and listed at the foot of each page. Where a claim cannot be verified, we say so directly rather than speculate.
Every page that addresses medication, dosing, contraindications, or clinical workflow is reviewed by Dr. A Kennah before publication. Clinical accuracy reviews are part of our standard publication process, not an optional layer.
If you believe any claim on this site is inaccurate — whether you're a provider, a patient, a clinician, or a regulator — please write to glpagonists@gmail.com with documentation of the issue. We post corrections inline on the affected page with a dated note. We do not silently rewrite published content.
This site uses privacy-respecting analytics. We do not run third-party advertising trackers and do not sell user data. Affiliate referrals are tracked via UTM parameters on outbound links so we can attribute sign-ups to specific pages and improve coverage; no personally identifying information is collected by GLP Agonists in the referral process.